Terms: = Endocrine gland cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Prognosis
16 results:
1. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
[TBL] [Abstract] [Full Text] [Related]
2. miR-551b is Associated with the Poor prognosis and Malignant Development of Papillary Thyroid cancer Through Regulating erbb4.
Wang J; Liu H
Horm Metab Res; 2022 Feb; 54(2):113-118. PubMed ID: 35130572
[TBL] [Abstract] [Full Text] [Related]
3. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
4. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of her4-mediated STAT5 pathway.
Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
[TBL] [Abstract] [Full Text] [Related]
5. A genetic variant of miR-335 binding site in the erbb4 3'-UTR is associated with prognosis of ovary cancer.
Wei P; Li L; Zhang Z; Zhang W; Liu M; Sheng X
J Cell Biochem; 2018 Jul; 119(7):5135-5142. PubMed ID: 29125883
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
[TBL] [Abstract] [Full Text] [Related]
7. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T
Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.
Koussounadis A; Langdon SP; Um I; Kay C; Francis KE; Harrison DJ; Smith VA
BMC Cancer; 2016 Mar; 16():205. PubMed ID: 26964739
[TBL] [Abstract] [Full Text] [Related]
9. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract] [Full Text] [Related]
10. Association between growth factor heregulin1α and receptors in growth of ovarian cancer cell line with high potentiality of peritoneal dissemination.
Nishiyama H; Soeda S; Watanabe T; Fujimori K
Fukushima J Med Sci; 2012; 58(1):22-32. PubMed ID: 22790889
[TBL] [Abstract] [Full Text] [Related]
11. Targeting EGFR in pancreatic cancer treatment.
Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
[TBL] [Abstract] [Full Text] [Related]
12. HER-family gene amplification and expression in resected pancreatic cancer.
te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ
Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440
[TBL] [Abstract] [Full Text] [Related]
13. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.
Lafky JM; Wilken JA; Baron AT; Maihle NJ
Biochim Biophys Acta; 2008 Apr; 1785(2):232-65. PubMed ID: 18291115
[TBL] [Abstract] [Full Text] [Related]
14. Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.
Horak E; Heitner T; Robinson MK; Simmons HH; Garrison J; Russeva M; Furmanova P; Lou J; Zhou Y; Yuan QA; Weiner LM; Adams GP; Marks JD
Cancer Biother Radiopharm; 2005 Dec; 20(6):603-13. PubMed ID: 16398612
[TBL] [Abstract] [Full Text] [Related]
15. [Relationship of expression of C-erbB2, C-erbB3, and C-erbb4 with ovarian carcinoma].
Li L; Zhong YP; Zhang W; Zhang JQ; Yao ZQ
Ai Zheng; 2004 May; 23(5):568-72. PubMed ID: 15142456
[TBL] [Abstract] [Full Text] [Related]
16. Granulosa cell tumors express erbb4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.
Furger C; Fiddes RJ; Quinn DI; Bova RJ; Daly RJ; Sutherland RL
Cancer Res; 1998 May; 58(9):1773-8. PubMed ID: 9581810
[TBL] [Abstract] [Full Text] [Related]
